Cellular Reprogramming Pill: Harvard/MIT researchers have developed chemical methods to reprogram human cells to a younger state using a single pill, a significant step toward reversing age-related decline.
Anti-IL11 Therapy: Experimental therapies inhibiting the protein interleukin 11 (IL11) have demonstrated a 25% increase in lifespan in pre-clinical studies, reducing frailty, reversing fat accumulation, and improving muscle function.
Next-Gen TOR Inhibitors (Rapalink-1): A new class of drugs that target the TOR pathway, crucial for managing age-related diseases like neurodegeneration and cancer, has shown potential in extending lifespan.
First Human Gene Therapy Trials: Following FDA clearance, human trials have begun for gene therapy designed to partially reverse cellular aging.
Artificial Skin & Tissue Engineering: Techniques to reverse skin aging and produce artificial, rejuvenated skin for transplantation are being developed to combat the decline of stem cells, according to research published in Nature.